| Autor: |
Gama MP; Departamento de Medicina Interna, Faculdade Evangélica do Paraná, Hospital Universitário Evangélico de Curitiba, Curitiba, RS. m.gama@sul.com.br, Pellegrinello S, Alonso SS, Coelho JF, Martins CF, Biagini GL |
| Jazyk: |
portugalština |
| Zdroj: |
Arquivos brasileiros de endocrinologia e metabologia [Arq Bras Endocrinol Metabol] 2005 Aug; Vol. 49 (4), pp. 604-9. Date of Electronic Publication: 2005 Oct 19. |
| DOI: |
10.1590/s0004-27302005000400021 |
| Abstrakt: |
Rhabdomyolysis has been the theme in medical literature for the last fifty years. In these last decades, with statins being used in primary and secondary cardiovascular prevention events, this theme returns and statins are now pointed as the trigger to this almost always fatal complication. Rhabdomyolysis due to statins administration occurs mainly in association with other drugs. Our case reports on a patient with fatal statin-induced rhabdomyolysis whose medical history included diffuse atherosclerotic disease. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
